Lysomale Speichererkankung

The Boa Constrictor

Pompe Disease

Pompe disease (also referred to as glycogenosis type II or acid maltase deficiency) is a rare, inherited metabolic disease caused by a deficiency of the enzyme acid glucosidase. This deficiency results in a progressive accumulation of glycogen in the lysosomes. Complete deficiency of this enzyme causes a pronounced cardiomyopathy, muscle weakness and feeding problems already during the first months of life. Without treatment, the children die in the first year of life. With residual enzyme activity a milder course of the disease is seen, charatcerized by increasing muscle weakness and/or breathing problems during adolescence and adulthood. Examination of blood samples shows increased activity of creatinine kinase (CK) and of liver enzymes.

Pompe Disease | SphinCS - Clinical Science for LSD

Synonym: Glycogen storage disease type II
Etiology: Deficiency of acid alpha-1,4-glucosidase
Gene: GAA Gene
Mode of inheritance: Autosomal recessive

  • Infantile form
  • Late-onset form 

Leading symptoms

Infantile form
(Age of onset: first months of life)

  • Cardiomyopathy
  • Muscular hypotonia „floppy infant“
  • Respiratory insufficiency
  • Psychomotor development delay/ arrest

Late-onset form
(Age of onset: variable, from childhood to adulthood)

  • Progressive proximale muscle weakness
  • Diaphragm weakness
  • Respiratory insufficiency
  • Sleep apnea


  • Diagnostics: - Measurement of the activity of acid alpha-1,4-glucosidase in lymphocytes or dried blood spot

  • Molecular genetic analysis of GAA Gene


Alglucosidase alfa (Myozyme®)

Aktuelle Studien

Zur Zeit finden keine Studien statt.

Die "U.S. National Library of Medicine" bietet unter eine vollständige Liste aller internationalen Studien. Die vergleichbare Website der EU ist nicht ganz so umfassend:


Zur Zeit sind uns keine Selbsthilfegruppen bekannt.


Zur Zeit liegt uns keine Literatur vor.